Staff editor
Industry
Sponsored by
This partnership emerges as a strategic move to capitalize on the expanding global microbiome market.
Industry
Sponsored by
Harnessing the benefits of L. plantarum PBS067, L. rhamnosus LRH020, and B. lactis BL050 for post-menopausal symptom relief.
Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.
MaaT Pharma indicates completion of patient recruitment for the Phase 2a RCT Evaluating MaaT013 in combination with immune checkpoint inhibitors in metastatic melanoma.
This strategic acquisition is set to reshape the landscape of microbiome research, extending its applications far beyond human health.
Scientific research, Video
Sponsored by
An open discussion about the future of microbiological analysis through AI integration with Franco Pirovano (Micro srl) and Federico Pirovano (Dynius).
Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex…
The study seeks to identify specific microbial and metabolic markers in the small intestinal fluid and blood of PD patients, offering new avenues for therapeutic intervention.
Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.
Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.
